Successful Treatment of Persistent SARS-CoV-2 Infection in a B-Cell Depleted Patient with Activated Cytotoxic T and NK Cells: A Case Report.
Int J Mol Sci
; 22(20)2021 Oct 10.
Article
in English
| MEDLINE | ID: covidwho-1463713
ABSTRACT
We report a lymphoma patient with profound B-cell deficiency after chemotherapy combined with anti-CD20 antibody successfully treated with remdesivir and convalescent plasma for prolonged SARS-CoV-2 infection. Viral clearance was likely attributed to the robust expansion and activation of TCR Vß2 CD8+ cytotoxic T cells and CD16 + CD56- NK cells. This is the first presentation of TCR-specific T cell oligoclonal response in COVID-19. Our study suggests that B-cell depleted patients may effectively respond to anti-SARS-CoV-2 treatment when NK and antigen-specific Tc cell response is induced.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Killer Cells, Natural
/
T-Lymphocytes, Cytotoxic
/
COVID-19
Type of study:
Case report
Limits:
Aged
/
Humans
Language:
English
Year:
2021
Document Type:
Article
Affiliation country:
Ijms222010934
Similar
MEDLINE
...
LILACS
LIS